A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

An England-wide study of over 58 million people has identified eight rare diseases that carry significantly increased risks for COVID-19-related mortality in fully vaccinated individuals. This ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

The organization representing Alberta physicians is calling out a government panel's COVID-19 report as “anti-science.” ...

The collapse reflects a widespread and mounting distrust of public health authorities, and the reason for that distrust is no mystery.

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

The World Health Organization on Tuesday urged the United States to reconsider its decision to suspend funding for HIV ...

Friday marked five years since a suburban hospital announced it was treating the first confirmed COVID-19 patient in Illinois ...

Thousands of Oklahomans are sick with the flu. Symptoms of influenza include chills, fever, cough and body aches.